Neoprobe

Science Vs. Hedge Funds: Influences On New Drug Approval Process
Seeking Alpha
Mon, 04/16/12 - 01:49 pm
hedge funds
Arena Pharmaceuticals
Avanir
Chelsea Therapeutics
Dendreon
Neoprobe
Vivus
Neoprobe Secures $10 Million in Debt Financing from Hercules
Thu, 01/5/12 - 12:45 pm
Neoprobe
debt
Hercules
Neoprobe Corporation Becomes Navidea Biopharmaceuticals
Thu, 01/5/12 - 12:44 pm
Neoprobe
Navidea Biopharmaceuticals
Neoprobe Announces Third Quarter 2011 Results
Wed, 10/26/11 - 10:12 pm
Neoprobe
earnings
OXiGENE and Neoprobe Reawaken Investor Interest in Biotechnology Industry
Fri, 10/21/11 - 06:37 pm
Oxigene
Neoprobe
investment
biotech
Neoprobe Receives FDA Acceptance of Lymphoseek® (tilmanocept) New Drug Application
Wed, 10/19/11 - 10:15 pm
Neoprobe
FDA
Neoprobe executives plan stock sell-off if FDA green-lights Lymphoseek
Sat, 09/24/11 - 03:28 pm
Neoprobe
FDA
Lymphoseek
Neoprobe Receives Positive Scientific Advice from European Medicines Agency (EMA) for RIGScan CR
Thu, 09/8/11 - 08:45 pm
Neoprobe
Europe
Medicine
Impressive Pipelines From Neoprobe and Ariad
Thu, 08/25/11 - 09:47 pm
pipelines
Neoprobe
Ariad
Neoprobe sheds device business; drug development now center stage
Thu, 08/18/11 - 09:43 pm
Neoprobe
Device
Drug
Devicor™ Medical Products, Inc. Completes Acquisition of Neoprobe's Gamma Detection Devices
Wed, 08/17/11 - 10:49 pm
Devicor
product
Neoprobe
Gamma
Neoprobe Completes Sale of Gamma Detection Device Business to Devicor Medical Products
Wed, 08/17/11 - 10:34 pm
Neoprobe
sale
Gamma
product
Neoprobe presses past controversy, submits Lymphoseek NDA| Regulatory Roundup
Thu, 08/11/11 - 11:06 pm
Neoprobe
Lymphoseek
regulatory
Neoprobe Submits New Drug Application for Lymphoseek
Wed, 08/10/11 - 04:21 pm
Neoprobe
Drug
Lymphoseek
Cell Therapeutics and Neoprobe Hope to Make 2011 a Banner Year
Fri, 07/29/11 - 10:55 pm
Cell Therapeutics
Neoprobe
Neoprobe Announces Second Quarter 2011 Results
Wed, 07/27/11 - 10:54 pm
Neoprobe
earnings
Neoprobe Establishes European Business Unit
Wed, 07/20/11 - 01:14 pm
Neoprobe
Should Biotech Investors Go Where Institutions Won't?
Investopedia
Thu, 07/7/11 - 12:04 pm
investors
biotech
Aeterna Zentaris
YM BioSciences
Ziopharm
Oncothyreon
Seattle Genetics
Exelixis
MannKind
MELA Sciences
Neoprobe
Zalicus
10 Biotech Trades for Second Half of 2011
TheStreet.com
Wed, 07/6/11 - 08:51 am
Sangamo BioSciences
BioSante
Seattle Genetics
YM BioSciences
Exelixis
Transcept
Oncothyreon
Gilead Sciences
Medivation
Neoprobe
Neoprobe: A Persuasive Biotech Speculative Investment
Fri, 06/17/11 - 07:02 pm
Neoprobe
tech
investment

Pages